Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer Metastatic
Sponsor: Samsung Medical Center